Amanda Lipsitt
Pediatric Hematology-Oncology · San Antonio, TXNPI 1194145300
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 26.1% of the total. 2025 is the largest year on record at $792, 2.4 times the $327 reported in 2019.
Across 48 payments — averaging $54.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$680
- Genetix Biotherapeutics Inc$416
- Novartis$339
- Sobi, Inc$281
- AstraZeneca$243
- Sanofi-aventis U.S. LLC$172
- plus $478 from 11 others
Across 41 payments — averaging $5222.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Autolus Inc$148K
- Novartis$66K
What the payments were for
- Food & beverage$2,40992%
- Education$2008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 18 | $680 |
| Genetix Biotherapeutics Inc | 3 | $416 |
| Novartis | 4 | $339 |
| Sobi, Inc | 5 | $281 |
| AstraZeneca(2 entities) | 3 | $243 |
| Sanofi-aventis U.S. LLC | 2 | $172 |
| Pharming Healthcare, Inc. | 3 | $149 |
| Adaptive Biotechnologies Corporation | 1 | $128 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Incyte Corporation | 1 | $26 |
| Photocure Inc | 1 | $24 |
| Mesoblast, Inc. | 1 | $24 |
| Novo Nordisk | 1 | $23 |
| Syndax Pharmaceuticals, Inc. | 1 | $21 |
| Genentech, Inc. | 1 | $19 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $19 |
| KARL Storz Endoscopy-america | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,609 in reported general payments places this provider in the 70th percentile of 235 pediatric hematology-oncology providers in Texas.
Other pediatric hematology-oncology in San Antonio
- Vinod Gidvani-DiazSan Antonio$101K
- Scott PenneySan Antonio$75K
- Chatchawin AssanasenSan Antonio$65K
- Samuel Pabon RiveraSan Antonio$23K
- Allison GrimesSan Antonio$21K
- Aaron SugalskiSan Antonio$9K
- Ghadir SasaSan Antonio$5K
- Lorimar RamirezSan Antonio$4K
- Mark GarciaSan Antonio$3K
- Anne-Marie LangevinSan Antonio$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.